NCT00510055

Completed

Treatment of Acne Scarring With a Novel Procedure Combinatio...

Northwestern University Source

Compare

Other study identifiers

Sponsor study identifier

STU752

Study Type

interventional

Actual enrollment (reported)

30

Locations

1 country

Sites

1

Timeline

Study Start

June 2007

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2009

Actual (reported)

Study Completion

July 2009

Actual (reported)

Brief Summary

The primary objective of this study is to look at the efficacy of subdermal manipulation and filler injection in the improvement of acne scar appearance.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 30 participants
Study completion date: July 2009
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
June 2007
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
July 31, 2007
Actual (reported)
First Posted
August 1, 2007
Actual (reported)
Primary Completion
July 2009
Actual (reported)
Study Completion
July 2009
Actual (reported)

Last Updated: December 2, 2021
Status Verified: November 2021
Last Update Submitted: November 30, 2021

Conditions

Acne Scarring

Outcome Measures

Primary Outcomes (1)

Scar Improvement
3.5 months

Secondary Outcomes (1)

Adverse Events
3.5 months

Study Arms (2)

A

EXPERIMENTAL

scars receive subdermal manipulation ONLY

Procedure: subdermal manipulation ONLY

B

EXPERIMENTAL

scars receive subdermal manipulation AND injection of a filler

Procedure: subdermal manipulation AND injection of a filler

Interventions

subdermal manipulation ONLYProcedure

scars receive subdermal manipulation ONLY

Also known as: subcision

A

subdermal manipulation AND injection of a fillerProcedure

scars receive subdermal manipulation AND injection of a filler

Also known as:

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Age 18 and over
Have two acne scar areas

Sponsors & Collaborators

Northwestern University
Otherlead

Study Sites (1)

Northwestern University Feinberg School of Medicine, Department of Dermatology

Chicago, Illinois, 60611, United States

MeSH Terms

Interventions

Prolaryn Plus

Study Officials

Murad Alam, MD
Northwestern University
PRINCIPAL INVESTIGATOR

Enrollment

30 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: OUTCOMES ASSESSOR
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Professor in Dermatology, Otolaryngology- Head and Neck Surgery, and Surgery-Organ Transplantation

Study Record Dates

First Submitted

July 31, 2007

First Posted

August 1, 2007

Study Start

June 2007

Date type not reported

This date has not been verified as actual or estimated.

NCT07078851

Comparing the Efficacy and Safety of Fractional Picosecond Laser and Gold Microneedle in the Treatment of Acne Scars

Not ApplicableCompleted

NCT07620769

Safety and Efficacy Evaluation of the Radiofrequency Therapeutic Device for the Treatment of Atrophic Acne Scars

Not ApplicableNot Yet Recruiting

Radiesse

B

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

The subjects are in good health

The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

You may not qualify if:

Under 18 years of age
Pregnancy or Lactation
Subjects who are unable to understand the protocol or to give informed consent
Subjects with mental illness

Contact the study team to confirm eligibility.

Primary Completion

July 2009

Actual (reported)

Study Completion

July 2009

Actual (reported)

Last Updated

December 2, 2021

Record last verified: 2021-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00510055
Data provider: ClinicalTrials.gov
Source updated: 2021-12-02
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:23:59 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

A

B

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations